Patent details

EP2258687 Title: Nicotinamide derivates useful as P38 inhibitors

Basic Information

Publication number:
EP2258687
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP101806933
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Nicotinamide derivates useful as P38 inhibitors
French Title of Invention:
Dérivés de nicotinamide utiles comme inhibiteurs de P38
German Title of Invention:
Nicotinamide und deren Verwendung als P38 Inhibitoren
SPC Number:

Dates

Filing date:
10/02/2003
Grant date:
26/12/2012
EP Publication Date:
26/12/2012
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/12/2010
EP B1 Publication Date:
26/12/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/02/2013
Expiration date:
10/02/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/02/2003
 
 

Name:
Glaxosmithkline LLC
Address:
One Franklin Plaza 200 North 16th Street, Philadelphia, PA 19102, United States (US)

Inventor

1

Name:
Bamborough Paul
Address:
United Kingdom (GB)

2

Name:
Aston Nicola, Mary
Address:
United Kingdom (GB)

3

Name:
Walker Ann, Louise
Address:
United Kingdom (GB)

Priority

1

Priority Number:
0203301
Priority Date:
12/02/2002
Priority Country:
United Kingdom (GB)

2

Priority Number:
0225385
Priority Date:
31/10/2002
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
C07D 213/82;
Filing date Document type Number of pages